Search Results 51-60 of 17374 for GLP-1 secretion

  1. Mayo Clinic Q and A: Low Blood Sugar a Concern for Patient With Diabetes

    Injections of [GLP-1] analogs [exenatide (Byetta) ... People with Type 1 diabetes who take insulin are at high risk of hypoglycemia. ... release of glucose into your ...

  2. Pilot Study to Quantify Insulin Synthesis and Secretion In Vivo - Mayo Clinic

    About this study. The purpose of this study evaluates a subset of people with isolated Impaired Fasting Glucose with Normal Glucose Tolerance (i.e., ...

  3. Diabetes treatment disparities widespread, room for improvement

    Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications. For ...

  4. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of Type 3c diabeTes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis - Mayo Clinic

    Subjects in the non-pancreatic disease subgroup (i.e., T2DM) on longer acting agents, including thiazolidinediones and once-weekly GLP-1 agonists (Bydureon ...

  5. Glipizide (oral route) - Mayo Clinic

    It stimulates the release of insulin from the pancreas, directing your body to store blood sugar. ... one or both of the medicines. ... You may report side effects ...

  6. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    ... GLP-1-based obesity medication semaglutide. No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr ...

  7. A Pilot Study Examining the Effect of Fasting Free Acid and Glucose Concentrations on Insulin Secretion - Mayo Clinic

    The purpose of this study is to determine if changes in fasting glucose and FFA concentrations alter 1st phase insulin secretion and proinsulin secretion in non ...

  8. Impact Of 1 Mg Osilodrostat Therapy On Mild Autonomous Cortisol Secretion (MACS) - Mayo Clinic

    Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. ... secretion (MACS), and to determine the impact ...

  9. Cardiometabolic Effects of Dipeptidyl Peptidase IV and Related Pathways - Mayo Clinic

    ... GLP-1, secondarily: improved glucose, insulin dynamics). ... History of gastrointestinal impairment such that would potentially affect absorption of oral glucose ...

  10. Empagliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Type 1 diabetic patients must use insulin injections. ... release tablets in children. Safety and efficacy ... If both medicines are prescribed together, your ...